title: Oral terbutaline for the treatment of priapism.
abstract: The widespread use of penile injections in the management of erectile dysfunction has led to an increased incidence of priapism. It has been suggested that terbutaline, a beta-agonist, might be beneficial in treating priapism in this setting. We randomized 24 patients with prolonged erections to a prospective, double-blind, placebo-controlled trial. We did not find any benefit of oral terbutaline over placebo in these patients.
authors.affiliation: Section of Urology, Virginia Mason Medical Center, Seattle, Washington.
authors.forename: F E
authors.initials: FE
authors.lastname: Govier
authors.forename: E
authors.initials: E
authors.lastname: Jonsson
authors.forename: D
authors.initials: D
authors.lastname: Kramer-Levien
mesh_terms: D000284:Administration, Oral; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D011317:Priapism / Q000188:drug therapy*; D011446:Prospective Studies; D013726:Terbutaline / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D013726:Terbutaline